Prospective, multicentric, randomized, open, comparative phase IV study evaluating the efficacy and safety of the dosage adjustment of Aprovel (irbesartan) in hypertensive outpatients in current clinical practice.
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2010
At a glance
- Drugs Irbesartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Sanofi
- 24 Dec 2007 New trial record.